I Will Not Be Pinkwashed: Komen's Race Is For Money, Not Cure
Continued from previous page
So how does it hope to accomplish its mission of finding a cure for breast cancer?
Research "for the Cure"
The first thing that pops into my mind when I think of a charity giant such as Komen funding research to prevent disease, is pouring money into Big Pharma’s pocketbook. After all, our only hope for a cure for cancer is that magical drug or vaccine that pharmaceutical corporations will one day rescue us all with, right?
Of course not.
But the reality that research in the conventional medical world is put toward, well, conventional medicine (allopathic drugs) remains. For me, this begs the question — where exactly does your research funding go, Komen?
SGK had the following to say regarding accusations that its organization funds pharmaceutical research:
“It’s been reported that Susan G. Komen for the Cure provides funding to pharmaceutical companies. That is simply not true. We have never funded pharmaceutical company research – our grants, totaling $450 million, have gone to research institutions in the U.S. and abroad.” – Susan G. Komen for the Cure
Ohh… okay. So you would never provide funding to pharmaceutical companies that sell disease-promoting, toxic chemical drugs to cancer patients.
But take their money? Sure!
“The Komen Foundation owns stock in General Electric, one of the largest makers of mammogram machines in the world. It also owns stock in several pharmaceutical companies, including AstraZeneca (now AzkoNobel).
AstraZeneca has long been a Komen booster, making educational grants to Komen and having a visible presence at the Race For the Cure. At the 1998 Food and Drug Administration hearings, the Komen Foundation was the only national breast cancer group to endorse the AstraZeneca cancer treatment drug tamoxifen as a prevention device for healthy but high-risk women, despite vehement opposition by most other breast cancer groups because of its links to uterine cancer.
The organization’s biggest sponsors are — surprise! — the corporations that profit from cancer through chemotherapy and radiation. To them, Komen for the Cure isn’t really about finding a cure for cancer; it’s about promoting cancer so that they can sell more drugs and radiotherapy that keeps more patients locked into a cycle of dependence on toxic cancer treatments.” -Well put, Natural News.
(Did you catch that bit about poisoning healthy women with the carcinogenic cancer drug, Tamoxifen, as a preventative measure? Yeah. Moving on…)
Susan G. Komen does indeed provide millions of dollars to fund research — but what exactly is it researching with those grants? One blogger diagnosed with metastatic breast cancer who had serious doubts of the intentions of the Komen foundation, dug through the research grants herself, and found the following information about how Komen’s research money is spent.
Its pie chart for all research spending from 1982-2010 says: treatment, 22%; early detection, 15%; etiology, 8%; prevention, 10%; model systems, 3%; survivorship, 9%; and biology, 33%.
Now, of those categories being researched, which sounds like it is actually focused on curing breast cancer?
Early detection? No.
Treatment? No. (That would be drugs used to treat symptoms.)
The only conceivable categories related to finding a cure for the cancer being researched would be etiology (the study of causation), survivorship, model systems, and biology.
So to break it down even further, Susan G. Komen for the Cure only spends a possible 53% of its research funding for a cure, or — about 11% of total revenue. Donate a dollar “for the cure?” Only about a dime of that will go toward research that might actually be designed to cure cancer, through allopathic medicine that is driven by the pharmaceutical system.